Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yasaman Taslimi, Nasrin Masoudzadeh, Fariborz Bahrami & Sima Rafati. (2022) Cutaneous leishmaniasis: multiomics approaches to unravel the role of immune cells checkpoints. Expert Review of Proteomics 19:3, pages 213-225.
Read now
Read now
Qiaohong Geng, Sagar O. Rohondia, Harras J. Khan, Peifu Jiao & Q. Ping Dou. (2020) Small molecules as antagonists of co-inhibitory pathways for cancer immunotherapy: a patent review (2018-2019). Expert Opinion on Therapeutic Patents 30:9, pages 677-694.
Read now
Read now
Articles from other publishers (2)
Soehartati A. Gondhowiardjo, Handoko, Vito Filbert Jayalie, Riyan Apriantoni, Andreas Ronald Barata, Fajar Senoaji, IGAA Jayanthi Wulan Utami, Ferdinand Maubere, Endang Nuryadi & Angela Giselvania. (2020) Tackling Resistance to Cancer Immunotherapy: What Do We Know?. Molecules 25:18, pages 4096.
Crossref
Crossref
Shuang Qin, Bing Dong, Ming Yi, Qian Chu & Kongming Wu. (2020) Prognostic Values of TIM-3 Expression in Patients With Solid Tumors: A Meta-Analysis and Database Evaluation. Frontiers in Oncology 10.
Crossref
Crossref